CUFinder

Purba Singh

Purba Singh

Baylor College of Medicine

H-index: 11

North America-United States

Contact Purba Singh

About Purba Singh

Purba Singh, With an exceptional h-index of 11 and a recent h-index of 11 (since 2020), a distinguished researcher at Baylor College of Medicine, specializes in the field of Molecular biology, Patient derived xenograft, Pre-clinical studies, Breast cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Kinase inhibitor pulldown assay (KiP) for clinical proteomics

Abstract GS01-08: CDK4/6 inhibition is a potential vulnerability in NF1-depleted ER+ breast cancer

Abstract PO2-14-11: Proteogenomic approaches for the identification of NF1/neurofibromin-depleted estrogen receptor positive breast cancers for targeted treatment

Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer

Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

Targeting kinome reprogramming in ESR1 fusion-driven breast cancer

Transcriptional reprogramming differentiates active from inactive ESR1 fusions in endocrine therapy-refractory metastatic breast cancer

Proteomics: A prospective new tool in forensic investigations

Purba Singh Information

University

Position

___

Citations(all)

791

Citations(since 2020)

708

Cited By

354

hIndex(all)

11

hIndex(since 2020)

11

i10Index(all)

12

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Purba Singh Skills & Research Interests

Molecular biology

Patient derived xenograft

Pre-clinical studies

Breast cancer

Top articles of Purba Singh

Kinase inhibitor pulldown assay (KiP) for clinical proteomics

Clinical Proteomics

2024/12

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Purba Singh
Purba Singh

H-Index: 10

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Abstract GS01-08: CDK4/6 inhibition is a potential vulnerability in NF1-depleted ER+ breast cancer

Cancer Research

2024/5/2

Eric Jaehnig
Eric Jaehnig

H-Index: 9

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Jonathan Lei
Jonathan Lei

H-Index: 9

Purba Singh
Purba Singh

H-Index: 10

Jin Cao
Jin Cao

H-Index: 11

Xi Chen
Xi Chen

H-Index: 13

Bora Lim
Bora Lim

H-Index: 22

Matthew Ellis
Matthew Ellis

H-Index: 1

Bing Zhang
Bing Zhang

H-Index: 40

Abstract PO2-14-11: Proteogenomic approaches for the identification of NF1/neurofibromin-depleted estrogen receptor positive breast cancers for targeted treatment

Cancer Research

2024/5/2

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Jonathan Lei
Jonathan Lei

H-Index: 9

Matthew Holt
Matthew Holt

H-Index: 16

Purba Singh
Purba Singh

H-Index: 10

Yongchao Dou
Yongchao Dou

H-Index: 16

Dan Ye
Dan Ye

H-Index: 6

Yunguan Wang
Yunguan Wang

H-Index: 6

Ariella Hanker
Ariella Hanker

H-Index: 13

Susan Hilsenbeck
Susan Hilsenbeck

H-Index: 53

Bora Lim
Bora Lim

H-Index: 22

Bing Zhang
Bing Zhang

H-Index: 40

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Matthew Ellis
Matthew Ellis

H-Index: 1

Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer

Cancer research

2023/10/2

Xuxu Gou
Xuxu Gou

H-Index: 9

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Purba Singh
Purba Singh

H-Index: 10

Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

Cancer Research Communications

2023/7/26

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Purba Singh
Purba Singh

H-Index: 10

Yongchao Dou
Yongchao Dou

H-Index: 16

Dan Ye
Dan Ye

H-Index: 6

Yunguan Wang
Yunguan Wang

H-Index: 6

Bora Lim
Bora Lim

H-Index: 22

Bing Zhang
Bing Zhang

H-Index: 40

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Targeting kinome reprogramming in ESR1 fusion-driven breast cancer

Cancer Research

2023/4/4

Xuxu Gou
Xuxu Gou

H-Index: 9

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Purba Singh
Purba Singh

H-Index: 10

Transcriptional reprogramming differentiates active from inactive ESR1 fusions in endocrine therapy-refractory metastatic breast cancer

Cancer research

2021/12/15

Xuxu Gou
Xuxu Gou

H-Index: 9

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Purba Singh
Purba Singh

H-Index: 10

Nicholas Mitsiades
Nicholas Mitsiades

H-Index: 41

Proteomics: A prospective new tool in forensic investigations

2021/7/1

S Kumar
S Kumar

H-Index: 25

The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells

Developmental cell

2021/4/19

Weijie Zhang
Weijie Zhang

H-Index: 9

Zhan Xu
Zhan Xu

H-Index: 3

Hai Wang
Hai Wang

H-Index: 15

Jun Liu
Jun Liu

H-Index: 8

William Wu
William Wu

H-Index: 5

Swarnima Singh
Swarnima Singh

H-Index: 4

Amit Goldstein
Amit Goldstein

H-Index: 3

Purba Singh
Purba Singh

H-Index: 10

Rachel Schiff
Rachel Schiff

H-Index: 17

Zhandong Liu
Zhandong Liu

H-Index: 33

Abstract PS17-03: Recurrent active ESR1 fusions render a diagnostic transcriptional signature in metastatic breast cancer

Cancer Research

2021/2/15

Xuxu Gou
Xuxu Gou

H-Index: 9

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Purba Singh
Purba Singh

H-Index: 10

Abstract PD8-02: kinome profiling of ER+ breast cancer PDXs identifies PKMYT1 as a marker of hormone independent growth and poor outcome

Cancer Research

2021/2/15

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Purba Singh
Purba Singh

H-Index: 10

Situación actual de la mancha foliar del trigo causada por Zymoseptoria tritici en México= Current status of the Septoria tritici blotch of wheat caused by Zymoseptoria tritici …

2020

Phenotypic plasticity of ER+ breast cancer in the bone microenvironment

bioRxiv

2020/11/15

Hai Wang
Hai Wang

H-Index: 15

Jun Liu
Jun Liu

H-Index: 8

Zhan Xu
Zhan Xu

H-Index: 3

Weijie Zhang
Weijie Zhang

H-Index: 9

William Wu
William Wu

H-Index: 5

Swarnima Singh
Swarnima Singh

H-Index: 4

Amit Goldstein
Amit Goldstein

H-Index: 3

Purba Singh
Purba Singh

H-Index: 10

Rachel Schiff
Rachel Schiff

H-Index: 17

Neurofibromin is an estrogen receptor-α transcriptional co-repressor in breast cancer

Cancer cell

2020/3/16

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Jin Cao
Jin Cao

H-Index: 11

Purba Singh
Purba Singh

H-Index: 10

Yue Chen
Yue Chen

H-Index: 8

Jing Li
Jing Li

H-Index: 19

Wei Song
Wei Song

H-Index: 12

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Jiejun Shi
Jiejun Shi

H-Index: 14

Xi Chen
Xi Chen

H-Index: 13

Bing Zhang
Bing Zhang

H-Index: 40

Wei Li
Wei Li

H-Index: 8

Abstract GS2-05: Microscaled proteogenomic methods for precision oncology

Cancer Research

2020/2/15

Shankha Satpathy
Shankha Satpathy

H-Index: 12

Eric Jaehnig
Eric Jaehnig

H-Index: 9

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Chen Huang
Chen Huang

H-Index: 0

Purba Singh
Purba Singh

H-Index: 10

Yongchao Dou
Yongchao Dou

H-Index: 16

Bo Wen
Bo Wen

H-Index: 16

Bing Zhang
Bing Zhang

H-Index: 40

Michael Gillette
Michael Gillette

H-Index: 5

Steven Carr
Steven Carr

H-Index: 1

Matthew Ellis
Matthew Ellis

H-Index: 1

Abstract P6-04-20: Proteogenomic analysis of estrogen modulated breast cancer metastasis

Cancer Research

2020/2/15

Purba Singh
Purba Singh

H-Index: 10

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Microscaled proteogenomic methods for precision oncology

Nature communications

2020/1/27

Shankha Satpathy
Shankha Satpathy

H-Index: 12

Karsten Krug
Karsten Krug

H-Index: 23

Beom-Jun Kim
Beom-Jun Kim

H-Index: 22

Meenakshi Anurag
Meenakshi Anurag

H-Index: 12

Chen Huang
Chen Huang

H-Index: 0

Purba Singh
Purba Singh

H-Index: 10

Yongchao Dou
Yongchao Dou

H-Index: 16

Bo Wen
Bo Wen

H-Index: 16

Rachel Schiff
Rachel Schiff

H-Index: 17

Bing Zhang
Bing Zhang

H-Index: 40

See List of Professors in Purba Singh University(Baylor College of Medicine)